6 Stemmingsstoornissen

American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: APA.

Anisman, H., Merali, Z., Poulter, M.O., & Hayley, S. (2005). Cytokines as a precipitant of depressive illness: animal and human studies. Current Pharmaceutical Design, 11, 963–972.CrossRefPubMed

Babyak, M., Blumenthal, J.A., Herman, S., e.a. (2000). Exercise treatment for majordepression: Maintenance of therapeutic benefit at 10 months. Psychosomatic Medicine, 62, 633–638.CrossRefPubMed

Beck, A.T. (1967). Depression: Clinical, experimental, and theoretical aspects. New York: Harper & Row.

Beck, J.S. (1999). Basisboek cognitieve therapie. Baarn: Intro.

Belanoff, J. (2002). An open label trial of C-1073 (mifepristone) for psychotic major depression. Biological Psychiatry, 52, 386–392CrossRefPubMed

Bockting, C.L., Schene, A.H., Spinhoven, P., e.a. (2005). Preventing relapse/recurrence in recurrent depression with cognitive therapy: A randomized control trial. Journal of Consulting and Clinical Psychology, 73(4), 647–657.CrossRefPubMed

Booij, L., Does, A.J.W. van der, Haffmans, P.N.J., e.a. (2005). The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients. Journal of Psychopharmacology, 19, 267–276.CrossRefPubMed

Caspi, A., Sugden, K., Moffitt, T.E., e.a. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301, 386–398.CrossRefPubMed

Collier, D.A., Arranz, M.J., Sham, P., e.a. (1996). The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neurological Report, 7, 1675–1679.

Coryell, W., Solomon, D., Turvey, C., e.a. (2003). The long-term course of rapid-cycling bipolar disorder. Archives of General Psychiatry, 60, 914–920.CrossRefPubMed

Danzer, R. (1999). Sickness behaviour: A neuroimmune-based response to infections. InM. Schedlowski & U. Tewes (red.), Psychoneuroimmunology: An interdisciplinary introduction. New York: Kluwer Academic/Plenum.

Dimidjian, S., Hollon, S., Dobson, K., e.a. (2006). Randomized trial of behavioural activation, cognitive therapy, and antidepressant medication in the acute treatment ofadults with major depression. Journal of Consulting and Clinical Psychology, 74, 658–670.CrossRefPubMed

Does, A.J.W. van der (2001). The effects of tryptophan depletion on mood and psychiatric symptoms. Journal of Affective Disorders, 64, 107–119.CrossRefPubMed

Does, A.J.W. van der (2002). Cognitive reactivity to sad mood: Structure and validity of a new measure. Behaviour Research and Therapy, 40, 105–120.CrossRefPubMed

Does, A.J.W. van der (2005). Dat moet mij weer gebeuren. .. Zwartkijkers, Zeurpieten en Pechvogels. Schiedam: Scriptum.

Does, A.J.W. van der (2005). Thought suppression and cognitive vulnerability to depression. British Journal of Clinical Psychology, 44, 1–14.CrossRefPubMed

Fergusson, D., Doucette, S., Cranley Glass, K., e.a. (2005). Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomized controlled trials. British Medical Journal, 19, 330–396.

Frank, E., Kupfer, D.J., Buysse, D.J, e.a. (2007). Randomized trial of weekly, twicemonthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression. American Journal of Psychiatry, 164, 761–767.CrossRefPubMedCentralPubMed

Frank, E., Swartz, H.A., & Kupfer, D.J. (2000). Interpersonal and social rhythm therapy: Managing the chaos of bipolar disorder. Biological Psychiatry, 48, 593–604.CrossRefPubMed

Glassman, A.H., & Shapiro, P.A. (1998). Depression and the course of coronary artery disease. American Journal of Psychiatry, 155, 4–11.CrossRefPubMed

Grunze, H., Kasper, S., Goodwin, G., e.a. (2003). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, Part II: Treatment of mania. World Journal of Biological Psychiatry, 4, 5–13.CrossRefPubMed

Grunze, H., Kasper, S., Goodwin, G., e.a. (2004). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, Part III: Maintenance treatment. World Journal of Biological Psychiatry, 5, 120–135.CrossRefPubMed

Hammen, C.L. (1991). The generation of stress in the course of unipolar depression. Journal of Abnormal Psychology, 100, 555–561.CrossRefPubMed

Harmer, C.J., Bhagwagar, Z., Perret, D.I., e.a. (2003). Accute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology, 28, 148–152.CrossRefPubMed

Henry, C., Sorbara, F., Lacoste, J., e.a. (2001). Antidepressant-induced mania in bipolar patients: Identification of risk factors. Journal of Clinical Psychiatry, 62, 249–255.CrossRefPubMed

Hindmarch, I. (2001). Expanding the horizons of depression: Beyond the monoamine hypothesis. Human Psychopharmacology, 16, 203–218.CrossRefPubMed

Hirschfeld, R.M., & Holzer, C.E. (1994). Depressive personality disorder: Clinical implications. Journal of Clinical Psychiatry, 55, Suppl. 266.

Huprich, S.K. (2001). The overlap of depressive personality disorder and dysthymia, reconsidered. Harvard Review of Psychiatry, 9, 158–168.CrossRefPubMed

Jacobsen, N.S., Doson, K.S., Truax, P.A., e.a. (1996). A component analysis of cognitive behavioural treatment for depression. Journal of Consulting and Clinical Psychology, 64, 295–304.CrossRef

Joiner, T.E. Jr., Steer, R.A., Abramson, L.Y., e.a. (2001). Hopelessness depression as a distinct dimension of depressive symptoms among clinical and non-clinical samples. Behaviour Research and Therapy, 39, 523–536.CrossRef

Judd, L.L., Akiskal, H.S., Maser, J.D., e.a. (1998). A prospective study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Archives of General Psychiatry, 55, 694–700.CrossRefPubMed

Kendler, K.S., Thornton, L.M., & Gardner, C.O. (2000). Stressful life events and previous episodes in the etiology of major depression in women: An evaluation of the ‘‘kindling’’ hypothesis. American Journal of Psychiatry, 157, 1243–1251.CrossRefPubMed

Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., & Walters, E. E. (2005). Life time prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62, 593–602.CrossRefPubMed

Kuehner, C., & Weber, I. (1999). Responses to depression in unipolar depressed patients: An investigation of Nolen-Hoeksema's response styles theory. Psychological Medicine, 29, 1323–1333.CrossRefPubMed

Kupka, R.W., Nolen, W.A., Altshuler, L.L., e.a. (2001). The Stanley Foundation Bipolar Network, 2: Preliminary summary of demographics, course of illness and response to novel treatments. British Journal of Psychiatry, Suppl, S177–183.

Kupka, R.W., & Nolen, W.A. (1999). Bipolaire stoornissen. In A. de Jong e.a. (red.), Handboek psychiatrische epidemiologie (pp. 280-299). Maarssen: Elsevier/De Tijdstroom. Lam, R.W., & Stewart, J.N. (1996). The validity of atypical depression in DSM-IV. Comprehensive Psychiatry, 37, 375–383.

Lewinsohn, P.M., Sullivan, J.M., & Grosscup, S.J. (1980). Changing reinforcing events: An approach to the treatment of depression. Psychotherapy: Theory, Research, and Practice, 47, 322–334.

Ma, S.H., & Teasdale, J.D. (2004). Mindfulness-based cognitive therapy for depression: Replication and exploration of differential relapse prevention effects. Journal of Clinical and Consulting Psychology, 72, 31–40.

Maier, S.F., Seligman, M.E.P. (1976). Learned helplessness: Theory and evidence. Journal of Experimental Psychology: General, 105, 3–46,CrossRef

Malouff, J.M., Thorsteinsson, E.B., & Schutte, N.S. (2005). The relationship between the five-factor model of personality and symptoms of clinical disorders: A meta-analysis. Journal of Psychopathology and Behavioral Assessment, 27, 101–114.

Mast, R.C. van der, Hengeveld, M.W., & Bannink, M. (1989). Depressies bij somatisch zieke patiënten. Nederlands Tijdschrift voor Geneeskunde, 133, 713–716.

Miklowitz D.J., Otto, M.W., Frank E., e.a. (2007). Psychosocial treatments for bipolar depression. Archives of General Psychiatry, 64, 419–426.CrossRefPubMedCentralPubMed

Miranda, J., & Persons, J.B. (1988). Dysfunctional attitudes are mood-state dependent. Journal of Abnormal Psychology, 97, 237–241.CrossRef

Mueller, T.I., Leon, A.C., Keller, M.B., e.a. (1999). Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. American Journal of Psychiatry, 156, 1000–1006.PubMed

Müller-Oerlinghausen, B, Berghöfer, A., & Bauer, M. (2001). Bipolar disorder. Lancet, 359, 241–247.CrossRef

Murray, C.J.L, & Lopez, A.D. (1996). Global health statistics. Cambridge (MA): Harvard University Press.

National Institute for Health and Clinical Excellence (2004). Depression: Management of depression in primary and secondary care. London: NICE.

Nolen W.A., & Knegtering, H. (1999). Farmacotherapie bij de manisch depressieve stoornis. In J.A. den Boer e.a. (red.). Handboek stemmingsstoornissen (pp. 232-245). Maarsen: Elsevier/De Tijdstroom

Nolen, W.A., Knoppert-van der Klein, E.A.M., Bouvy, P.F., e.a. (1998). Richtlijn farmacotherapie bipolaire stoornissen. Meppel: Boom.

Nolen, W.A., Luckenbaugh, D.A., Altshuler, L.L., e.a. (2004). Correlates of 1-year prospective outcome in bipolar disorder: Results from the Stanley foundation bipolar network. American Journal of Psychiatry, 161, 1447–1454.CrossRefPubMed

Nolen-Hoeksema, S.N., Morrow, J., & Fredrickson, B.L. (1993). Reponse styles and the duration of episodes of depressed mood. Journal of Abnormal Psychology, 102, 20–28.CrossRefPubMed

Ogilvie, A.D., Battersby, S., Bubb, V.J., e.a. (1996). Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet, 347, 731–733.CrossRefPubMed

Olivier B. (2004). Serotonin and aggression. Annals of the New York Academy of Science, 1036, 382–392.CrossRef

Ormel, J. (1999). De rol van levensgebeurtenissen, persoonlijkheid en erfelijkheid. In J.A. den Boer e.a. (red.), Handboek stemmingsstoornissen (pp. 133-155). Maarssen: Elsevier/De Tijdstroom.

Ormel, J., & Sytema, S. (1999). Epidemiologische aspecten van stemmingsstoornissen. In J.A. den Boer e.a. (red.), Handboek stemmingsstoornissen (pp. 50-71). Maarssen: Elsevier/De Tijdstroom.

Ormel, J., Rosmalen, J., & Farmer, A. (2004). Neuroticism: A non-informative marker of vulnerability to psychopathology. Social Psychiatry and Psychiatric Epidemiology, 39, 906–912CrossRefPubMed

Pampallona, S., Bollini, P., Tibaldi, G., e.a., (2004). Combined pharmacotherapy and psychological treatment for depression: A systematic review. Archives of General Psychiatry, 61,714–719.CrossRefPubMed

Penninx, B.W.J.H., Geerlings, S.W., Deeg, D.J.H., e.a. (1999). Minor and major depression and the risk of death in older persons. Archives of General Psychiatry, 56, 889–895.CrossRefPubMed

Peselow, E.D., Sanfilipo, M.P., Fieve, R.R., & Gulbenkian, G. (1994). Personality traits during depression and after clinical recovery. British Journal of Psychiatry, 164, 349–354.CrossRefPubMed

Post, R.M. (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry, 149, 999–1010.CrossRefPubMed

Praag, H.M. van, Kloet, R. de, Os, J. van (2004). Stress, the brain and depression. Cambridge: Cambridge University Press.

Rush, A.J., Giles, D.E., Schlesser, M.A., e.a. (1996). The dexamethasone suppression test in patients with mood disorders. Journal of Clinical Psychiatry, 57, 470–484.CrossRefPubMed

Quitkin, F.M. (1999). Placebos, drug effects, and study design: A clinician's guide. American Journal of Psychiatry, 156, 829–836.CrossRefPubMed

Robertson, M.M., & Katona. C.L.E. (red.) (1997). Depression and physical illness. Chichester: Wiley.

Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S. e.a. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301, 805–809.CrossRefPubMed

Segal, Z.V., Kennedy, S., Gemar, M., Hod, K., & Pederson, R. (2006). Cognitive reactivity to sad mood provocation and the prediction of depressive relapse. Archives of General Psychiatry, 63, 749–755.CrossRefPubMed

Simons, A.D., Garfield, S.L., & Murphy, G.E. (1984). The process of change in cognitive therapy and pharmacotherapy for depression: changes in mood and cognition. Archives of General Psychiatry, 41, 45–51.CrossRefPubMed

Sjoberg, R.L., Nilsson, K.W., Nordquist, N., e.a. (2005) Development of depression: sex and the interaction between environment and a promoter: Polymorphism of the serotonin transporter gene. International Journal of Neuropsychopharmacology, 9, 1–7.CrossRef

Spijker, J., Graaf, R. de, Bijl, R.V., e.a. (2002). Duration of major depressive episodes in the general population: Results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). British Journal of Psychiatry, 181, 208–213.CrossRefPubMed

Sullivan, P.F., Neale, M.C., & Kendler, K.S. (2000). Genetic epidemiology of major depression: A review and meta-analysis. American Journal of Psychiatry, 157(10), 1552–1562.CrossRefPubMed

Teasdale, J.D. (1988). Cognitive vulnerability to persistent depression. Cognition and Emotion, 2, 247–274.CrossRef

Teasdale, J.D., Segal, Z.V., Williams, J.M.G., e.a. (2000). Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Journal of Consulting and Clinical Psychology, 68, 615–623.CrossRefPubMed

Tennant, C. (2002). Life events, stress and depression: A review of recent findings. Australian and New Zealand Journal of Psychiatry 36(2), 173–182.CrossRefPubMed

Trimbos-instituut (2005). Multidisciplinaire richtlijn depressie. Utrecht: Trimbos-instituut/Kwaliteitsinstituut voor de gezondheidszorg (www.cbo.nl).

Üstun, T.B., Ayuso-Mateos, J.L., Chatterji, S., Mathers, C., & Murray, J.L. (2004). Global burden of depressive disorders in the year 2000. British Journal of Psychiatry, 184, 286–392.CrossRef

Üstun, T.B., Chatterji, S. (2001). Global burden of depressive disorders and future projections. In A. Dawson & A. Tylee (eds.), Depression: Social and economic timebomb. Genève: World Health Organization / Londen: BMJ Books.

Vollebergh, W., De Graaf, R., Ten Have, M. e.a. (2003). Psychische stoornissen in Nederland. Overzicht van de resultaten van Nemesis. Utrecht: Trimbos-instituut.

Wade, T.D., & Kendler, K.S. (2000). The relationship between social support and major depression: Cross-sectional, longitudinal, and genetic perspectives. Journal of Nervous & Mental Disease, 188, 251–258.CrossRef

Watkins, E., & Moulds, M. (2005). Positive beliefs about rumination in depression: A replication and extension. Personality and Individual Differences, 39, 73–82.CrossRef

Weel-Baumgarten, E. van, Bosch, W. van den, Hoogen, H. van den, & Zitman, F.G , (1998). Ten year follow-up of depression after diagnosis in general practice. British Journal of General Practice, 48, 1643–1646.

Weissman, M.M., Bland, R.C., Canino, G.J., e.a. (1996). Cross-national epidemiology of major depression and bipolar disorder. Journal of the American Medical Association, 276, 293–299.CrossRefPubMed

Wheeler Vega, J.A., Mortimer, A.M., & Tyson, P.J. (2000). Somatic treatment of psychotic depression: Review and recommendations for practice. Journal of Clinical Psychopharmacology, 20, 504–519.CrossRefPubMed

Wolpert, L. (2001). Malignant sadness: The anatomy of depression. London: Faber & Faber. Young, S.N., Smith, S.E., Pihl, R.O., & Ervin, F.R. (1985). Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology, 87, 173–177.

Zammit, S., & Owen, M.J. (2006). Stressful life events, 5-HTT genotype and risk of depression. British Journal of Psychiatry, 188, 199–201.CrossRefPubMed

Bohn Stafleu van Loghum

6 Stemmingsstoornissen

Samenvatting

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen